GlassScriptPhysician profile
Joseph E Freschi
NPI 1063494060
$5,400.12
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,289 · 2020: $1,670 · 2021: $2,150 · 2022: $61.10 · 2023: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $552.39 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $455.36 | 2019-2021 | |
| Abbvie INC. | $435.16 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $396.83 | 2019-2021 | |
| Allergan, INC. | $304.26 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $250.36 | 2020-2021 | |
| Ucb, INC. | $237.33 | 2020-2021 | |
| Horizon Therapeutics Plc | $230.00 | 2023 | Uplizna |
| Amgen INC. | $199.55 | 2019-2021 | |
| Emd Serono, INC. | $198.12 | 2019-2022 | |
| Lilly USA, LLC | $185.64 | 2019-2021 | |
| Harmony Biosciences LLC | $183.76 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $166.64 | 2019-2021 | |
| Pfizer INC. | $165.55 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $165.39 | 2019-2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Freschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.